Valeo Partners

Valeo Pharma is a Canadian specialty pharmaceutical company focused on the acquisition and commercialization of innovative prescription products. The company primarily targets therapeutic areas such as respiratory health, specialty products, and medical aesthetics, acting as a strategic partner for international pharmaceutical firms entering the Canadian market. Valeo's portfolio includes key products such as Redesca for thrombosis and the asthma therapies Enerzair Breezhaler and Atectura Breezhaler. By leveraging a robust commercial infrastructure, the company aims to provide high-value healthcare solutions while expanding its footprint in the North American specialty pharma sector.